1. Home
  2. AZTA vs IOVA Comparison

AZTA vs IOVA Comparison

Compare AZTA & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$18.60

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.04

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
IOVA
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
AZTA
IOVA
Price
$18.60
$4.04
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$40.60
$9.00
AVG Volume (30 Days)
770.5K
15.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
14.84
EPS
N/A
N/A
Revenue
$593,821,000.00
N/A
Revenue This Year
$6.99
$47.74
Revenue Next Year
$5.98
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.87
$1.64
52 Week High
$41.73
$5.63

Technical Indicators

Market Signals
Indicator
AZTA
IOVA
Relative Strength Index (RSI) 31.51 62.57
Support Level N/A $2.03
Resistance Level $32.32 $4.33
Average True Range (ATR) 1.45 0.21
MACD -0.43 0.06
Stochastic Oscillator 11.89 99.38

Price Performance

Historical Comparison
AZTA
IOVA

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: